El interés en corto de Walgreens Boots Alliance da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Walgreens Boots Alliance. Los datos de interés en corto se actualizan cada dos semanas.

Walgreens Boots Alliance (NASDAQ:WBA) Bolsa, Informe de interés en corto

WALGREENS BOOTS ALLIANCE INC

Walgreens Boots Alliance

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Walgreens Boots Alliance Inc. WBA

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

CALM

LEVI

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este martes: WBA, GBX, RPM, LEVI y CALM.

5 acciones en el foco este martes: WBA, GBX, RPM, LEVI y CALM

Microstrategy, Qualcomm, Arm Holdings, Ford, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Equities

AVGO

COST

LUNR

TSLA

El mercado de valores cayó con fuerza ayer. Descubre qué acciones fueron las más negociadas y cómo impactó la jornada en los traders.

Broadcom, Costco, Intuitive Machines, Walgreens y Tesla: 5 acciones que están en el radar de los inversores

AAPL

INTC

El mercado de valores de EE.UU. cerró en positivo pese al débil crecimiento del PIB. Descubre qué acciones sorprendieron a los inversores.

Apple, Intel, Walgreens, UPS y Tesla: 5 acciones que están en el radar de los inversores

Walgreens Boots Alliance, Inc. - Common Stock

Walgreens Boots Alliance Inc

WisdomTree Trust Wisdomtree Battery Value Chain Fd

U.S. futures rose on Friday following Thursday&#8217;s rally. Futures of major benchmark indices were trading higher.
The U.S. and China have finalized a trade understanding, building on an agreement reached last month in Geneva.
U.S. Commerce Secretary Howard Lutnick <a href="https://www.benzinga.com/news/politics/25/06/46133537/howard-lutnick-confirms-us-china-trade-agreement-reaffirms-white-houses-progress-to-close-deals-wit">confirmed the deal with China</a>, which was signed two days ago, noting that the White House has immediate plans to secure agreements with ten other major trading partners. 
The accord with China codifies terms established during recent trade discussions between <a href="https://www.benzinga.com/news/macro-notification/25/06/45876366/howard-lutnick-says-us-and-china-reached-a-framework-to-implement-geneva-consensus-following-trump-xi-call-csi-300-index-gains">Beijing and Washington</a>. 
The 10-year Treasury bond yielded 4.27% and the two-year bond was at 3.75%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool&#8217;s</a> projections show markets pricing a 79.3% likelihood of the Federal Reserve keeping the current interest rates unchanged in its July meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.23%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.22%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.29%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.25%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Friday. The SPY was up 0.27% at $613.54, while the QQQ advanced 0.33% to $548.03, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro </a>data.
Cues From Last Session:
Most sectors on the S&amp;P 500 closed positively on Thursday, led by significant gains in communication services, consumer discretionary, and energy stocks.
This broad upward movement contributed to U.S. stocks settling higher. However, real estate and consumer staples stocks diverged from the overall market trend, ending the day lower.
Individual company performances also bolstered the market. Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) reported better-than-expected earnings for the third quarter, while Worthington Steel, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) shares surged by over 20% after the company announced stronger-than-expected financial results for its fourth quarter.
On the economic front, the first-quarter GDP saw a downward revision to -0.5% from the previously reported -0.2%. This revision was primarily attributed to a widening goods trade deficit, influenced by weaker exports.
Despite this adjustment, other economic indicators released on Thursday painted a more optimistic picture.
Factory orders in May demonstrated a robust increase, soaring by 16.4% month-over-month to $343.6 billion, marking the largest surge since July 2014. This impressive figure far exceeded market expectations of an 8.5% gain, following a revised 6.6% drop in April.
Furthermore, weekly jobless claims fell by 10,000 to 236,000 in the week ending June 21, surpassing economists&#8217; forecasts of no change and signaling continued resilience in the labor market.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.97%</td>
<td>20,167.91</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.80%</td>
<td>6,141.02</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.94%</td>
<td>43,386.84</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.68%</td>
<td>2,172.11</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
With July beginning next week, Ryan Detrick of Carson Research highlighted historical data, citing that the seventh month of the year has seen consistent gains for 10 years in a row.
&#8220;The S&amp;P 500 has gained in July for an incredible 10 years in a row. One more and it ties the longest win streak ever,&#8221; he posted on X.
The graph shared by him showed that one more month of positive gains in the month of July will make this streak of 11 years equal to another 11-year-long streak from the 1950s.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">As I discussed with <a href="https://twitter.com/FrankCNBC?ref_src=twsrc%5Etfw">@FrankCNBC</a> this morning, the S&amp;P 500 has gained in July for an incredible 10 years in a row. One more and it ties the longest win streak ever. <a href="https://t.co/6BrkJNCcUC">pic.twitter.com/6BrkJNCcUC</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1938258076794061101?ref_src=twsrc%5Etfw">June 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Ed Yardeni of Yardeni Research highlighted that his firm has been observing and agreeing with the notion that the stock market rally since April 9 suggests that investors believe that the tariff issue will be mostly behind us by the end of the summer.
On April 9, President Donald Trump postponed his April 2 Liberation Day reciprocal tariffs for 90 days.
Trump&#8217;s Tariff Turmoil has had &#8220;remarkably little impact on the forward profit margin of the S&amp;P 500 so far. It has been essentially flat since the start of this year but at roughly a record high of 13.7%,&#8221; he said.
Meanwhile, Louis Navellier said that &#8220;The AI theme is alive and well, best demonstrated by the renewed confidence in Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), which is taking semiconductors and software along for the ride.&#8221;
&#8220;While longer term, the AI story is to eliminate a lot of white-collar jobs, we have yet to see that put a dent in unemployment numbers. The offset is that the jobs will be going away because AI is cheaper, which should drive corporate profit margins higher.&#8221;
See Also:<a href="https://www.benzinga.com/money/how-to-trade-futures"> How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Friday:
<ul class="wp-block-list">
<li>May&#8217;s personal income, spending, and headline and core PCE Index data will be released by 8:30 a.m. ET.</li>
<li>Final consumer sentiment data will be released by 10:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>Apogee Enterprises Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APOG#NASDAQ">APOG</a>) was up 1.90% in premarket on Friday as analysts expect it to report quarterly earnings of 47 cents per share on revenue of $325.48 million, before the opening bell.</li>
<li>Cineverse Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNVS#NASDAQ">CNVS</a>) rose 1.67% as analysts expect it to report a loss of 7 cents per share on revenue of $14.29 million, after the closing bell.</li>
<li>Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) jumped 9.67% after reporting better-than-expected fourth-quarter financial results for fiscal 2025. The company reported fourth-quarter revenue of $11.1 billion, beating analyst estimates of $10.72 billion.</li>
<li>American Outdoor Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) gained 11.20% after posting upbeat fourth-quarter results. American Outdoor Brands reported quarterly adjusted earnings of 13 cents per share, which beat the analyst consensus estimate for losses of 11 cents per share.</li>
<li>Concentrix Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) tumbled 8.40% after reporting mixed second-quarter results after Thursday's closing bell. Concentrix reported quarterly earnings of $2.70 per share, which missed the analyst consensus estimate of $2.75.</li>
<li>Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) rose 4.87% after reports that Uber Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NASDAQ">UBER</a>) is in talks to help fund a takeover deal with the company.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 0.81% to hover around $65.77 per barrel.
Gold Spot US Dollar fell 1.25% to hover around $3,286.11 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was lower by 0.54% at the 97.1550 level.
Asian markets ended lower on Friday, except Japan's Nikkei 225 and India's S&amp;P BSE Sensex indices. While Australia's ASX 200, China&#8217;s CSI 300, South Korea's Kospi, and Hong Kong's Hang Seng indices declined. European markets were higher in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46108861/microsoft-is-playing-chess-and-others-are-playing-checkers-dan-ives-says-msft-could-be-a-5-trillion-company-in-18-months">Microsoft Is &#8216;Playing Chess, And Others Are Playing Checkers:&#8217; Dan Ives Says MSFT Could Be A $5 Trillion Company In 18 Months</a></li>
</ul>
Photo courtesy: Shutterstock

AOUT

APOG

CNVS

CNXC

NVDA

PONY

UBER

US Stocks Likely To Open Higher As Commerce Secretary Confirms Deal With China: Nike, Worthington Steel Surge Amid Upbeat Earnings

The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Thursday.
U.S. stocks settled higher on Thursday, with the Dow Jones index gaining more than 400 points during the session.
Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) on Thursday reported better-than-expected earnings for the third quarter. Worthington Steel, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) shares jumped more than 20% on Thursday as the company reported stronger-than-expected financial results for the fourth quarter.
On the economic front, the first-quarter GDP was revised downward to -0.5% from the previous -0.2% figure, primarily due to a widening goods trade deficit linked to weaker exports. Yet, other data released Thursday painted a more positive picture.
Factory orders in May soared by 16.4% month-over-month to $343.6 billion, marking the biggest increase since July 2014. That followed a revised 6.6% drop in April and smashed market expectations of an 8.5% gain. Weekly jobless claims fell by 10,000 to 236,000 in the week ending June 21, while economists had forecast no change — another sign of labor market resilience.
Most sectors on the S&amp;P 500 closed on a positive note, with communication services, consumer discretionary and energy stocks recording the biggest gains on Thursday. However, real estate and consumer staples stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 404 points to 43,386.84 on Thursday. The S&amp;P 500 rose 0.80% to 6,141.02, while the Nasdaq Composite climbed 0.97% to 20,167.91 during Thursday's session.
Investors are awaiting earnings results from Apogee Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APOG#NASDAQ">APOG</a>) and Cineverse Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNVS#NASDAQ">CNVS</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 63, the index remained in the &#8220;Greed&#8221; zone on Thursday, versus a prior reading of 58.2.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next:<a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46115042/top-2-tech-and-telecom-stocks-you-may-want-to-dump-in-june"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46115042/top-2-tech-and-telecom-stocks-you-may-want-to-dump-in-june">Top 2 Tech And Telecom Stocks You May Want To Dump In June</a> </li>
</ul>
Photo courtesy: Shutterstock

Dow Jumps Over 400 Points Amid Upbeat Earnings: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

Wall Street entered full rally mode on Thursday, with the Nasdaq 100 extending its record-setting climb and the S&amp;P 500 approaching its February peak, as easing geopolitical fears and renewed hopes for a dovish Federal <a href="https://www.benzinga.com/topic/federal-reserve">Reserve lifted investor sentiment.</a>
By midday in New York, the S&amp;P 500 was up 0.7% to 6,136, just nine points shy of its all-time high of 6,145. The Nasdaq 100 rose another 0.7% to 22,400, marking yet another intraday record.
Meanwhile, small caps surged, with the Russell 2000 jumping 1%, outperforming the broader market.
On the macro front, the first-quarter GDP was revised downward to -0.5% from the previous -0.2% figure, primarily due to a widening goods trade deficit linked to weaker exports. Yet, other data released Thursday painted a more positive picture.
Factory orders in May soared by 16.4% month-over-month to $343.6 billion, marking the biggest increase since July 2014. That followed a revised 6.6% drop in April and smashed market expectations of an 8.5% gain. Weekly jobless claims fell by 10,000 to 236,000 in the week ending June 21, while economists had forecast no change — another sign of labor market resilience.
Currency markets added fuel to the equity rally. The U.S. dollar index fell to 97, its lowest level since February 2022, as traders increasingly bet that the next Fed chair nominee — with a <a href="https://www.benzinga.com/author/piero-cingari">shortlist reportedly down to four or five names</a> — will favor a dovish stance, potentially setting the stage for deeper rate cuts in 2026.
All S&amp;P 500 sectors traded in the green, except real estate. Energy stocks outperformed, rebounding after sharp down days as crude oil prices rose 2% to $66 per barrel.
Other commodities — especially metals — also rose, fueled by dollar weakness. Silver rose 1.2%, while palladium and <a href="https://www.benzinga.com/markets/commodities/25/06/46120819/platinum-miners-forecasts-stocks">platinum</a> spiked 6.1% and 4.3%, respectively. Copper rose 2.8% hitting a three-month high, while gold held steady at $3,330 per ounce.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) was unchanged at $107,220. 
<h1 class="wp-block-heading">Thursday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices </td>
<td>Price</td>
<td>% Chg</td>
</tr>
<tr>
<td>• Russell 2000</td>
<td>2,158.05</td>
<td>+1.0%</td>
</tr>
<tr>
<td>• Dow Jones</td>
<td>43,355.44</td>
<td>+0.9%</td>
</tr>
<tr>
<td>• Nasdaq 100</td>
<td>22,403.44</td>
<td>+0.7%</td>
</tr>
<tr>
<td>• S&amp;P 500</td>
<td>6,136.45</td>
<td>+0.7%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) rose 0.66% to $563.41.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.8% to $433.26.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;soared 0.7% to $544.72.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rallied 1% to $214.05.</li>
<li>The&nbsp;Energy&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 1.5%; the&nbsp;Real Estate&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>) lagged, down 0.8%.</li>
</ul>
<h1 class="wp-block-heading">Thursday&#8217;s Stock Movers</h1>
<ul class="wp-block-list">
<li>Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) surged past $155 per share to hit record highs, becoming the world's most valuable company at $3.8 trillion.</li>
<li>Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) slipped 1.1%, even after delivering <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46121658/micron-impresses-wall-street-with-strong-q3-earnings-continued-strength-in-ai-data-center">stronger-than-expected quarterly earnings</a>.</li>
<li>Other stocks reacting to earnings included Acuity Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>), up 7.1%; McCormick Company Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>), up 5.2% and Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>), up 0.8%.</li>
<li>Freeport-McMoRan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) jumped 8%, lifted by rising metal prices, with industry peers Southern Copper Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCCO#NYSE">SCCO</a>), Albemarle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>), and Alcoa Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) all rallying between 7% and 8%.</li>
<li>Equinix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) sank 8% after unveiling a long-term growth outlook that underwhelmed investors.</li>
<li>Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) will report earnings after the close. </li>
</ul>
Read Now:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/commodities/25/06/46120819/platinum-miners-forecasts-stocks">Platinum&#8217;s Biggest Rally In 40 Years: These 6 Mining Stocks Could Be Top Gainers </a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Large Cap

Broad U.S. Equity ETFs

Commodities

Tech

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

EQIX

SCCO

XLRE

Stocks Rally To New Highs, Dollar Tumbles To 40-Month Lows: What's Driving Markets Thursday?

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday.
The Dow traded up 0.82% to 43,335.29 while the NASDAQ gained 0.69% to 20,110.81. The S&amp;P 500 also rose, gaining, 0.66% to 6,132.29.
Check This Out: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46113083/amd-taiwan-semiconductor-manufacturing-cnbc-final-trades">AMD, Taiwan Semiconductor And A Financial Stock On CNBC&#8217;s &#8216;Final Trades&#8217;</a>
Leading and Lagging Sectors Materials shares jumped by 0.9% on Thursday.
In trading on Thursday, real estate stocks fell by 1%.
Top Headline
Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) on Thursday reported better-than-expected earnings for the third quarter on Thursday.
The company posted third-quarter sales of $38.99 billion, up 7.2% year over year (+6.9% on constant currency), beating the consensus of $36.84 billion, reflecting sales growth in the U.S. Retail Pharmacy and International segments. Adjusted EPS was 38 cents, down from 63 cents a year ago, beating the consensus of 34 cents, according to data from Benzinga Pro.
Walgreens Boots Alliance withdrew its 2025 guidance as part of the M&amp;A deal with Sycamore Partners. The merger is expected to close in the fourth quarter of calendar year 2025.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Cyngn Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares shot up 277% to $18.83 after the company announced it partnered with Nvidia to showcase its autonomous industrial vehicles at Automatica 2025.</li>
<li>Shares of Ascent Solar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) got a boost, surging 113% to $2.4799 after the company entered into a collaborative agreement with NASA.</li>
<li>Worthington Steel, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) shares were also up, gaining 13% to $29.69 as the company reported stronger-than-expected financial results for the fourth quarter.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Globavend Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) shares dropped 74% to $0.1835 after the company announced the pricing of a $15 million offering of 21,739,130 shares at $0.69 per share.</li>
<li>Shares of Altimmune, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) were down 56% to $3.4133 after the company announced topline results from the IMPACT Phase 2b trial of Pemvidutide in the treatment of MASH.</li>
<li>Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) was down, falling 54% to $0.3502 after the company announced a $10 million public offering of 20 million shares and dual warrants at a combined price of $0.50 per share and accompanying warrants.</li>
</ul>
Commodities In commodity news, oil traded up 1.3% to $65.79 while gold traded down 0.2% at $3,335.10.
Silver traded up 0.9% to $36.420 on Thursday, while copper rose 3% to $5.1200.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.01%, while Spain's IBEX 35 Index rose 0.03%. London's FTSE 100 rose 0.23%, Germany's DAX 40 gained 0.38% and France's CAC 40 slipped 0.11% during the session.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei gaining 1.65%, Hong Kong's Hang Seng Index falling 0.61%, China's Shanghai Composite falling 0.22% and India's BSE Sensex rising 1.21%.
Economics
<ul class="wp-block-list">
<li>The U.S. economy shrank at an annualized rate of 0.5% in the first quarter, compared to a 0.2% decline as per the second estimate.</li>
<li>U.S. initial jobless claims declined by 10,000 from the previous week to 236,000 in the week ended June 21.</li>
<li>U.S. durable goods orders climbed by 16.4% month-over-month to $343.6 billion in May compared to a revised 6.6% decline in April.</li>
<li>The U.S. trade deficit in goods increased to $96.6 billion in May from $87.0 billion in the previous month, and versus market estimates of an $88.5 billion gap.</li>
<li>The Chicago Fed National Activity Index rose to –0.28 in May compared to a revised reading of –0.36 in April.</li>
<li>U.S. wholesale inventories declined 0.3% month-over-month to $905.4 billion in May following a revised 0.1% gain in April.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46108846/nike-likely-to-report-lower-q4-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Nike Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>
Photo: Shutterstock

Intraday Update

Movers

ASTI

RVPH

Crude Oil Gains Over 1%; Walgreens Posts Upbeat Earnings

Walgreens Boots Alliance Inc&nbsp;(NASDAQ:&nbsp;WBA) on Thursday reported third-quarter sales of $38.99 billion, up 7.2% year over year (+6.9% on constant currency), beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $36.84 billion</a>, reflecting sales growth in the&nbsp;U.S.&nbsp;Retail Pharmacy&nbsp;and International segments.
Adjusted operating income&nbsp;was&nbsp;$558 million&nbsp;compared to $613 million&nbsp;in the year-ago quarter, reflecting higher incentive accruals, lower&nbsp;U.S.&nbsp;retail sales, and lower equity earnings in Cencora, partly offset by growth in&nbsp;U.S. Healthcare&nbsp;and cost savings <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b46111781/walgreens-boots-alliance-reports-fiscal-2025-third-quarter-results" rel="noreferrer noopener">within&nbsp;U.S. Retail Pharmacy</a>.
Adjusted EPS was&nbsp;38 cents, down from 63 cents a year ago, beating the consensus of 34 cents, according to data from&nbsp;<a target="_blank" href="https://benzinga.grsm.io/register174?tblci=GiCUX7wvU_AgmIIiQduNYr6JQuJQLy6SZJGvpyeZuCzyqiCN1VcoxvTN4f7-y-PqATDviEo" rel="noreferrer noopener">Benzinga Pro</a>.
CEO Tim Wentworth, said, "Third quarter results reflect continued improvement in our&nbsp;U.S. Healthcare&nbsp;segment and benefits from our cost savings initiatives, while we continued to see weakness in our&nbsp;U.S.&nbsp;front-end sales. We remain focused on our turnaround plan, which will require time, disciplined focus and a balanced approach to manage future cash needs with investments necessary to navigate an evolving pharmacy and retail environment."
Also Read: <a target="_blank" href="https://www.benzinga.com/news/health-care/25/06/45753489/amazon-pharmacy-challenges-cvs-health-and-walgreens-dominance-unveils-new-features-to-expand-medicare-access" rel="noreferrer noopener">Amazon Pharmacy Challenges CVS Health And Walgreens Dominance, Unveils New Features To Expand Medicare Access</a>
The U.S. Retail Pharmacy segment sales reached $30.7 billion, up 7.8%. Comparable sales increased 10.3%.
Pharmacy sales increased 11.8%, and comparable pharmacy sales increased 14.6% in the quarter, each benefiting from higher branded drug inflation and mix impacts.
Comparable prescriptions increased by 2.7%, and prescriptions excluding immunizations increased by 2.7% compared to a year ago.
Total prescriptions filled in the quarter, including immunizations, increased 0.4% to 308 million.
Retail sales decreased 5.3%, including the impact of the Footprint Optimization Program and lower comparable retail sales. Comparable retail sales decreased 2.4% and were impacted by weaker sales in grocery and household, health and wellness, and beauty.
The U.S. Healthcare segment reported third-quarter sales of $2.1 billion, a decrease of $23 million, primarily driven by a 6.5% decrease in VillageMD sales, reflecting lower risk-based and fee-for-service revenue, including the impact of clinic closures. CareCentrix sales increased 11.6%, and Shields sales increased 24.8%.
Guidance: Walgreens Boots Alliance <a href="https://www.benzinga.com/general/health-care/25/04/44685591/walgreens-boots-alliance-q2-earnings-beats-expectations-suspends-guidance-amid-pending-private-equity-deal-with-sycamore-partners" target="_blank" rel="noreferrer noopener">withdrew its 2025 guidance </a>as part of the M&amp;A deal with Sycamore Partners. The merger is expected to close in the <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44182479/walgreens-stock-rises-as-company-inks-10b-deal-to-go-private" target="_blank" rel="noreferrer noopener">fourth quarter of calendar year 2025</a>.
Price Action:&nbsp;WBA stock is up 0.62% at $11.38 during the premarket session at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/macro-economic-events/25/06/46113383/us-china-trade-deal-could-be-finalized-next-week-says-harvard-scholar-they-are-going-to-stabilize-this" target="_blank" rel="noreferrer noopener">US-China Trade Deal Could Be Finalized Next Week, Says Harvard Scholar: &#8216;They Are Going To Stabilize This&#8217;</a></li>
</ul>
Photo: 2p2play / Shutterstock.com

Health Care

General

Walgreens Crushes Sales Forecast, But Deeper Retail Troubles Lurk Beneath

Walgreens Boots Alliance Q3 2025 Adj. EPS $0.38 Beats $0.34 Estimate, Sales $38.99B Beat $36.84B Estimate

U.S. futures rose on Thursday after a mixed close on Wednesday. Futures of major benchmark indices were trading higher.
During his testimony to Congress, Federal Reserve Chair Jerome Powell signaled slower growth and hotter inflation after the central bank left interest rates unchanged.
President Donald Trump, who has been pushing the Fed to cut rates, said that he could announce Powell&#8217;s successor by September, whose term ends later in May 2026, <a href="https://www.wsj.com/economy/central-banking/trump-next-federal-reserve-chair-powell-d3edcb9c?mod=hp_lead_pos1">reported</a> the Wall Street Journal. 
The 10-year Treasury bond yielded 4.28% and the two-year bond was at 3.76%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 75.2% likelihood of the Federal Reserve keeping the current interest rates unchanged in its July meeting.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.20%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.26%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.40%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.12%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Thursday. The SPY was up 0.28% at $608.84, while the QQQ advanced 0.41% to $543.36, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Information technology and communication services stocks bucked the overall market trend, closing higher on Wednesday, while most sectors on the S&amp;P 500 closed on a negative note, with real estate, consumer staples, and utilities recording the biggest losses.
At a NATO meeting in the Netherlands, President Trump stated that a ceasefire between Israel and Iran remains in effect, and the United States will persist in pressuring Tehran. He clarified that while sanctions are still in place, Iran is presently permitted to sell oil to China.
Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) spearheaded chipmaker gains, increasing 3.6% and reaching its highest level since early December 2024. Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares also surged 4.3% on Wednesday.
On the economic front, U.S. sales of new single-family homes decreased by 13.7% from the previous month, reaching an annualized rate of 623,000 units in May. U.S. building permits declined by 2% to an annualized rate of 1.394 million in May.
The Dow Jones index ended 507 points or 0.25% lower at 42,982.43, whereas the S&amp;P 500 index fell 0.0003% to 6,092.16. Nasdaq Composite advanced 0.31% to 19,973.55, and the small-cap gauge, Russell 2000, tumbled 1.16% to end at 2,136.18.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.31%</td>
<td>19,973.55</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.00033%</td>
<td>6,092.16</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.25%</td>
<td>42,982.43</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.16%</td>
<td>2,136.18</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Liz Ann Sonders, the chief investment strategist at Schwab, said that the Middle East remains unstable, but maybe not as unstable as it looked a few days ago, so the market shook off the fear and rose.
&#8220;There was a spike in oil and concerns over the weekend and what futures signaled Sunday night, but things aren&#8217;t as bad as expected, and we&#8217;re not seeing escalation, so markets rallied.&#8221;
Talking about international equities, Brock Weimer, an investment strategist at Edward Jones, said that &#8220;We believe the more compelling opportunity lies in U.S. equities over the next one to three years. As part of our opportunistic asset-allocation guidance, we recommend a slight underweight to international developed equities in favor of U.S. stocks.&#8221;
Meanwhile, Louis Navellier commented on Powell&#8217;s Congress testimony and said, &#8220;So, despite the fact that three other Fed members are now signaling a July key interest rate cut, Chairman Powell remains a hawk and continues to ignore favorable inflation data as well as lower Treasury yields.&#8221;
&#8220;The Fed has been anticipating an inflation &#8216;bogeyman&#8217; that has not materialized. Central banks around the world continue to cut key interest rates. Deflation is becoming increasingly common around the world, especially in China,&#8221; Navellier said.
Talking about the U.S. dollar, he said he expects the U.S. dollar to &#8220;firm up&#8221; due to;
(1) higher interest rates compared to the rest of the world, (2) stronger economic growth, and (3) military might.
&#8220;A strong U.S. dollar is also naturally deflationary, since commodities are priced in U.S. dollars,&#8221; he added.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a> 
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Thursday:
<ul class="wp-block-list">
<li>May&#8217;s advanced U.S. trade balance in goods, retail inventories, and wholesale inventories, along with the initial jobless claims data for the week ended June 21, will be released by 8:30 a.m. ET.</li>
<li>May&#8217;s headline and core durable-goods orders and second revision for the first quarter GDP will also be released at 8:30 a.m. ET.</li>
<li>Cleveland Fed President Beth Hammack will speak at 9:00 a.m., and pending home sales for May will be out by 10:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) was up 0.27% in premarket on Thursday as analysts expect it to report quarterly earnings of 34 cents per share on revenue of $36.84 billion, before the opening bell.</li>
<li>Acuity Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) advanced 1.35% as analysts expect it to report quarterly earnings of $4.43 per share on revenue of $1.15 billion, before the opening bell.</li>
<li>Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) was 0.74% higher as analysts expect it to report quarterly earnings of 13 cents per share on revenue of $10.72 billion after the closing bell.</li>
<li>McCormick &amp; Company Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) rose 0.84% as analysts expect it to report quarterly earnings of 65 cents per share on revenue of $1.66 billion, before the opening bell.</li>
<li>Worthington Steel Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) jumped 16.15% after reporting stronger-than-expected financial results for the fourth quarter. The company reported quarterly earnings of $1.05 per share, which beat the analyst consensus estimate of 82 cents per share.</li>
<li>Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) was up 2.18% after reporting better-than-expected financial results for the third quarter after the market closed on Wednesday. The company said it expects fourth-quarter revenue of $10.7 billion, plus or minus $300 million, versus estimates of $9.88 billion.</li>
<li>Bumble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMBL#NASDAQ">BMBL</a>) gained 0.61% after announcing 30% of job cuts and restructuring plans.</li>
<li>Bit Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) tumbled 3.83% commenced an underwritten public offering of its ordinary shares, with all shares being offered by the company.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 0.15% to hover around $65.02 per barrel.
Gold Spot US Dollar rose 0.29% to hover around $3,341.87 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was lower by 0.54% at the 97.1550 level.
Asian markets ended lower on Thursday, except Japan's Nikkei 225 and India's S&amp;P BSE Sensex indices. While Australia's ASX 200, China&#8217;s CSI 300, South Korea's Kospi and Hong Kong's Hang Seng advanced. European markets were mostly higher in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46109917/billionaire-david-tepper-dumps-nvidia-slashes-magnificent-7-holdings-but-bets-big-on-these-2-ai-and-blockchain-plays">Billionaire David Tepper Dumps Nvidia, Slashes &#8216;Magnificent 7&#8217; Holdings — But Bets Big On These 2 AI And Blockchain Plays</a></li>
</ul>
Photo courtesy: godongphoto / Shutterstock.com

BMBL

BTBT

US Stocks Likely To Open Higher Despite Powell's Tariff-Induced Inflation Warning: Walgreens, Nike In Focus Ahead Of Earnings

<h3>Companies Reporting Before The Bell</h3>
• HIVE Digital Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIVE#NASDAQ">HIVE</a>) is projected to report quarterly loss at $0.11 per share on revenue of $31.47 million. 
• Orion Energy Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OESX#NASDAQ">OESX</a>) is projected to report quarterly loss at $0.03 per share on revenue of $21.08 million. 
• Lindsay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNN#NYSE">LNN</a>) is expected to report quarterly earnings at $1.40 per share on revenue of $157.90 million. 
• Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) is projected to report quarterly earnings at $0.34 per share on revenue of $36.72 billion. 
• McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) is estimated to report quarterly earnings at $0.66 per share on revenue of $1.66 billion. 
• Acuity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) is estimated to report quarterly earnings at $4.49 per share on revenue of $1.16 billion. 
<h3>Companies Reporting After The Bell</h3>
• Origin Agritech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEED#NASDAQ">SEED</a>) is likely to report earnings for its first quarter. 
• Aethlon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) is estimated to report earnings for its fourth quarter. 
• Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $10.70 billion. 
• American Outdoor Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) is projected to report quarterly loss at $0.11 per share on revenue of $48.46 million. 
• Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) is estimated to report quarterly earnings at $2.75 per share on revenue of $2.38 billion. 
• Enerpac Tool Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAC#NYSE">EPAC</a>) is projected to report quarterly earnings at $0.47 per share on revenue of $162.20 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEMD

EPAC

HIVE

OESX

SEED

Earnings Scheduled For June 26, 2025

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Wednesday.
U.S. stocks settled mixed on Wednesday, with the Dow Jones index falling more than 100 points during the session.
At a NATO meeting in the Netherlands, President Donald Trump said that a ceasefire between Israel and Iran remains in place and that the United States will continue exerting pressure on Tehran. He clarified that while sanctions remain, Iran is currently allowed to sell oil to China.
Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) led chipmaker gains, rising 3.6% and reaching its highest level since early December 2024. NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares jumped 4.3% on Wednesday.
On the economic front, sales of new single-family homes in the U.S. dipped by 13.7% from the previous month to an annualized rate of 623,000 units in May. U.S. building permits declined by 2% to an annualized rate of 1.394 million in May.
Most sectors on the S&amp;P 500 closed on a negative note, with real estate, consumer staples and utilities stocks recording the biggest losses on Wednesday. However, information technology and communication services stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 107 points to 42,982.43 on Wednesday. The S&amp;P 500 fell 0.02 points to 6,092.16, while the Nasdaq Composite climbed 0.31% at 19,973.55 during Wednesday's session.
Investors are awaiting earnings results from Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>), Acuity Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) and NIKE, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 58.8, the index remained in the &#8220;Greed&#8221; zone on Wednesday, versus a prior reading of 57.1.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46093486/top-2-utilities-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Utilities Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo courtesy: Shutterstock

Nasdaq Settles Higher As Nvidia, AMD Rally: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) will release earnings results for the third quarter, before the <a href="https://www.benzinga.com/quote/WBA/earnings">opening bell on Thursday, June 26.</a>
Analysts expect the Deerfield, Illinois-based company to report quarterly earnings at 34 cents per share, down from 63 cents per share in the year-ago period. Walgreens projects to report quarterly revenue of $36.72 billion, compared to $36.35 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Walgreens on April 21 said it will pay $300 million to resolve federal allegations that the company filled millions of invalid prescriptions for opioids and other controlled substances.
Walgreens shares fell 0.4% to close at $11.31 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/WBA/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Deutsche Bank analyst George Hill downgraded the stock from Hold to Sell and cut the price target from $11 to $9 on Feb. 28, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Truist Securities analyst David Macdonald maintained a Hold rating and cut the price target from $13 to $12 on Jan. 31, 2025. This analyst has an accuracy rate of 65%.</li>
<li>UBS analyst Kevin Caliendo maintained a Neutral rating and raised the price target from $9 to $10 on Oct. 17, 2024. This analyst has an accuracy rate of 70%.</li>
<li>Morgan Stanley analyst Erin Wright maintained an Underweight rating and cut the price target from $9 to $7 on Oct. 11, 2024. This analyst has an accuracy rate of 75%.</li>
</ul>
Considering buying WBA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/WBA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="627" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26020627/image-391-1024x627.png" alt="" class="wp-image-962557" style="width:636px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26020627/image-391-1024x627.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26020627/image-391-300x184.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26020627/image-391-768x471.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26020627/image-391.png 1126w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46093486/top-2-utilities-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Utilities Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo via Shutterstock

Price Target

Analyst Ratings

Top Wall Street Forecasters Revamp Walgreens Expectations Ahead Of Q3 Earnings

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
<ul class="wp-block-list">
<li>Wall Street expects Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) to report quarterly earnings at 34 cents per share on revenue of $36.84 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Walgreens shares gained 0.1% to $11.32 in after-hours trading.</li>
<li>Worthington Steel Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) reported stronger-than-expected financial results for the fourth quarter. The company reported quarterly earnings of $1.05 per share, which beat the analyst consensus estimate of 82 cents per share. Worthington Steel shares jumped 14.2% to $30.00 in the after-hours trading session.</li>
<li>Analysts are expecting Acuity Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) to post earnings at $4.43 per share on revenue of $1.15 billion for the latest quarter. The company will release earnings before the markets open. Acuity shares rose 1.4% to $291.37 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul class="wp-block-list">
<li>Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) reported better-than-expected financial results for the third quarter after the market closed on Wednesday. The company said it expects fourth-quarter revenue of $10.7 billion, plus or minus $300 million, versus estimates of $9.88 billion. The company anticipates fourth-quarter adjusted earnings of $2.50 per share, plus or minus 15 cents, versus estimates of $2.01 per share. Micron shares rose 0.9% to $128.40 in the after-hours trading session.</li>
<li>Analysts expect NIKE, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) to post quarterly earnings at 13 cents per share on revenue of $10.72 billion after the closing bell. Nike shares rose 0.1% to $60.91 in the after-hours trading session.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46093486/top-2-utilities-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Utilities Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo courtesy: 2p2play / Shutterstock.com

Walgreens, Micron Technology And 3 Stocks To Watch Heading Into Thursday

Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) is preparing to release its quarterly earnings on Thursday, 2025-06-26. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Walgreens Boots Alliance to report an earnings per share (EPS) of $0.34.
Investors in Walgreens Boots Alliance are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
The company's EPS beat by $0.11 in the last quarter, leading to a 1.79% increase in the share price on the following day.
Here's a look at Walgreens Boots Alliance's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.52</td>
<td>0.37</td>
<td>0.36</td>
<td>0.71</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.63</td>
<td>0.51</td>
<td>0.39</td>
<td>0.63</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>28.000000000000004%</td>
<td>6.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1750885233_0.png" alt="eps graph" />
<h3>Walgreens Boots Alliance Share Price Analysis</h3>
Shares of Walgreens Boots Alliance were trading at $11.35 as of June 24. Over the last 52-week period, shares are down 7.22%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/WBA/earnings">To track all earnings releases for Walgreens Boots Alliance visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Look Ahead: Walgreens Boots Alliance's Earnings Forecast

The U.S. markets will be closed on Thursday, June 19, in observance of Juneteenth National Independence Day, a federal holiday commemorating the end of slavery in the United States.
What Happened: According to the guidance from the Securities Industry and Financial Markets Association, the New York Stock Exchange and the Nasdaq will both suspend trading for the day, along with the U.S. bond market, which will also remain closed. Trading will resume as normal on Friday, June 20.
Juneteenth is the newest federal holiday in the calendar, having been designated only in 2021 by former President Joe Biden, 156 years after Major General Gordon Granger ordered the final enforcement of the Emancipation Proclamation in Texas on June 19, 1865.
See Also: <a href="https://www.benzinga.com/news/politics/25/06/46010064/ayatollah-assassination-discussion-rejected-by-putin-i-do-not-even-want-to-discuss-this-possibility">Ayatollah Assassination Discussion Rejected By Putin: &#8216;I Do Not Even Want To Discuss This Possibility&#8217;</a>
The decision to make this a national holiday was undertaken following <a href="https://www.benzinga.com/news/24/06/39397814/is-the-market-open-on-juneteenth">months of widespread protests</a> against racial injustice and inequality in 2020. 
While financial markets will be off on Thursday, not all sectors will stop functioning. Most federal government offices, bank branches, schools, and even the U.S. Postal Service will be shutting down, with many state and local government offices also observing the holiday.
Private companies, however, aren&#8217;t required by law to close for federal holidays, and retailers such as Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), Target Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>), and Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) will continue <a href="https://edition.cnn.com/2025/06/18/business/open-closed-juneteenth">to</a> remain open during their normal working hours. 
Major banks such as JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) and Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), among others, will be closed, while online banking and ATMs will continue to function. 
Why It Matters: For years, Juneteenth celebrations were <a href="https://www.benzinga.com/news/22/06/27699154/juneteenth-2022-whats-open-whats-closed-and-what-is-the-holiday-all-about-1">restricted only to Texas</a>, but following the unrest that stemmed from the death of George Floyd in 2020, there were growing calls for making it a nationwide holiday.
Besides Juneteenth, the markets remain closed for <a href="https://www.benzinga.com/money/stock-market-holidays">eight other federal holidays</a>, with the following occasions in the coming months,
<ul class="wp-block-list">
<li>Friday, July 4th—Independence Day</li>
<li>Friday, September 5th—Labor Day</li>
<li>Monday, November 24th—Thanksgiving</li>
<li>Friday, December 26th—Christmas Day</li>
</ul>
Photo Courtesy: iHumnoi on Shutterstock.com Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46010451/peter-schiff-doesnt-think-stablecoins-will-help-preserve-dollar-dominance-heres-what-the-economist-says-theyll-do-instead">Peter Schiff Doesn&#8217;t Think Stablecoins Will Help Preserve Dollar Dominance — Here&#8217;s What The Economist Says They&#8217;ll Do Instead</a></li>
</ul>

Are Markets Open On Juneteenth This Year? Here's What's Open And What's Closed On June 19

The best investments you will ever make in your entire life are those in sectors and opportunities where almost nobody else agrees with you.
The consensus holds that the asset class you are reviewing is terrible and investing there will almost certainly lead to immediate and severe loss of funds.
Right at this moment, as we survey Wall Street and Main Street, it is probably easier to find eight-year-old kids looking forward to a dinner of liver and onions with chicken gizzards and broccoli than openly enthusiastic advocates of investing in commercial real estate.
When you take an asset class this universally hated and discover that only private equity professionals truly love it, I start to get interested.
Recently, KKR &amp; Co (Ticker: KKR) came out and waxed poetic about opportunities in commercial real estate debt, pointing out severe price contractions. Low prices tend to bring out buyers and dealmakers, exactly what we are seeing.
John Gray at Blackstone (Ticker: BX) has emerged as a vocal advocate, pounding the table that this is the time to be opportunistic and aggressive. Gray came up through Blackstone&#8217;s real estate division and knows these markets intimately. His firm has generated tremendous returns for themselves and investors in commercial real estate.
When the best minds in private equity begin to pick at and nibble around a sector, it is generally time to start getting interested.
When I examine commercial real estate, offices immediately come to mind. The conventional wisdom holds that offices are empty, and nobody will ever work in them again. People envision office space as something from a post-apocalyptic movie.
In a word, bleak.
The forecast appears terrible.
Workers want to stay home in their sweatpants with dress shirts and ties for Zoom (Ticker: ZM) calls.
That paradigm is shifting. We have completed our work-from-home experiment. The office decline is beginning to ebb, stabilizing at a new, lower baseline.
Across the country, return-to-work policies are emerging. Financial services led the charge. The federal government has made it official policy. State and local governments are following suit.
Artificial intelligence companies are mandating office returns, recognizing that breakthrough innovation requires massive collaborative efforts that demand physical presence.
Return-to-work mandates represent just one factor.
Construction has virtually stopped. Even developers interested in office construction cannot secure financing for new projects.
According to a recent CBRE Group (Ticker: CBRE) report, the math has fundamentally shifted. The combined number of office conversions, to life science buildings, medical facilities, condominiums, and residential buildings, plus outright demolitions exceeds new supply coming to market in many U.S. markets.
We are witnessing the creation of a supply-constrained office market, particularly for Class A space where everyone wants to locate.
Within just a few years, we will face a supply-and-demand imbalance resulting in an actual shortage of high-end Class A office space.
This trend is emerging everywhere, even in battered markets like San Francisco. There, AI-related office space has grown fivefold over recent years and is projected to triple again over the next five years.
&nbsp;Demand is building while new supply remains nonexistent. Office real estate is beginning to improve, yet nobody is paying attention.
For three to four years running, I have heard predictions that multifamily real estate will collapse. These forecasts began with the initial post-pandemic surge that elevated multifamily values.
The reality is we face a massive affordability crisis in residential real estate. Three factors have created a perfect storm: older homeowners with no intention of moving, persistently high mortgage rates, and builders correctly focused on higher-margin market segments.
This combination has eliminated supply at the market&#8217;s lower end.
Estimates of the housing shortage range from two million to six million units, with the true number likely between four and five million.
We face an absolute shortage of new single-family and attached homes (think townhouses rather than condominiums).
Substantial new supply will not come online until older homeowners who own much of existing inventory either pass away or are convinced by their children to relocate. Something must break this logjam.
The mathematics are stark: older homeowners hold mortgages below four percent, creating zero incentive to sell and generate new inventory.
New construction requires tax and economic incentives to make first-time and move-up home building financially viable for developers. That relief remains distant.
The Mortgage Brokers Association forecasts no significant pickup in single-family housing activity over the next several years, nor any meaningful decline in mortgage rates.
Paradoxically, if mortgage rates do fall meaningfully, it will signal that economic activity has ground to a halt, creating different affordability problems entirely.
This dynamic sustains strong multifamily demand. An entire demographic cohort that would typically have purchased homes remains trapped in apartments.
These demographic shifts are creating apartment demand surges. The substantial building wave over recent years to meet post-COVID demand filled immediately upon completion. Construction is decelerating as financing becomes more selective. Lenders will only finance the best apartment complexes in the hottest, highest-end markets.
This pullback makes multifamily commercial real estate particularly attractive, especially if acquired during broader market sell-offs.
Logistics and industrial real estate has emerged as the hottest market, driven by global supply chain restructuring and e-commerce growth. Warehousing has migrated from central districts to locations closer to cities and towns.
&nbsp;Currently, everyone is holding their breath over trade uncertainties and their potential impact on global logistics and supply chains.
This too shall pass.
The underlying demand remains robust. While we experienced a supply surge as supply chains were remade following early COVID disruptions, that wave is now ebbing.
Demand has remained strong, existing supply is filling up, and occupancy rates are very high. The outlook for industrial and logistics real estate remains very positive.
Retail properties present a bifurcated market similar to office real estate. Second and third-tier malls are finished, destined for the dustbin of history. However, Class A malls with premier tenants, exceptional entertainment and dining options, and high-end retail remain fantastic businesses.
Outlet malls continue to thrive.
Open-air centers that are internet-resistant featuring grocery stores, gyms, medical offices, and pharmacies are performing exceptionally well.
Single-tenant net lease retail properties represent another compelling opportunity. These include Walgreens(Ticker: WBA), Starbucks (Ticker: SBUX), Home Depot (Ticker: HD), Walmart (Ticker: WMT), McDonald&#8217;s (Ticker: MCD), Burger King (Ticker: QSR), and other standalone businesses.
When you examine the four corners of any major city intersection, those corner buildings typically house net lease, single-tenant real estate. This is one of my favorite segments of the real estate market and a fantastic business model.
Most commercial real estate sectors are performing well. The only serious problems have been concentrated in downtown office buildings, and even there, the combination of constrained new supply, return-to-work mandates, conversions, and demolitions is generating meaningful market improvement.
This presents an opportune time to consider commercial real estate investments: direct property ownership, commercial real estate companies, servicing companies, and non-REIT companies that own real estate assets. Real opportunity exists here because no one on Wall Street that I am aware of is advocating for commercial real estate and commercial real estate services. Numerous companies are flying well under the radar, potentially offering huge long-term returns for patient, aggressive investors willing to step into the liver and onions of current financial markets.
FRP Holdings (Ticker: FRPH) embodies everything I discussed about commercial real estate opportunities. This Jacksonville, Florida-based holding company operates across four distinct segments that perfectly capture the themes I believe are driving the commercial real estate renaissance: Industrial and Commercial properties, Mining Royalty Lands, Development, and Multifamily residential.
The crown jewel of FRP Holding's portfolio remains largely invisible to most investors.
It is approximately 16,650 acres under lease for mining rents or royalties and an additional 4,280 acres through its Brooksville joint venture with Vulcan Materials. These properties contain reserves totaling over 500 million tons, representing decades of steady cash flow.
I find the mining segment particularly attractive because it brings in approximately $10 million annually in revenue with roughly 90% free cash flow margin, generating $9 million in free cash flow.
Think about that mathematics for a moment. &nbsp;
This represents the purest form of real estate investment, land that generates income without the headaches of tenant management, building maintenance, or capital expenditure cycles. The mining royalty business provides FRP Holdings with a steady foundation of cash flow that supports their more aggressive development activities.
I also like FRP Holding's multifamily portfolio concentration in the Washington D.C. market, exactly where I want exposure as a real estate investor. D.C. is fairly recession-resistant since the federal government is the biggest employer in the area.
The company owns interests in multiple apartment complexes including Dock 79, The Maren, The Verge, Bryant Street, and .408 Jackson through joint ventures.
The strategic positioning becomes clear when you examine FRP Holding's development pipeline. The company has executed an agreement with Steuart Investment Company and MidAtlantic Realty Partners for the development of up to ten mixed-use projects in the Capitol Riverfront and Buzzard Point submarkets of Washington, D.C.
&nbsp;Upon completion and stabilization, these projects will comprise over 3 million square feet of mixed-use development including 3,000 residential units and 150,000 square feet of retail.
I see FRP Holding's industrial segment perfectly capturing the trends I discussed earlier about logistics and warehousing demand.
The company entered into two new joint venture agreements in early 2024 with Altman Logistics. The first joint venture is a 200,000 square-foot warehouse development project in Lakeland, FL, and the second joint venture is a 182,000 square-foot warehouse redevelopment project in Broward County, FL.
Shell construction on their spec warehouse project in Aberdeen, MD on Chelsea Road was completed effective April 1, 2025, and is in the lease-up phase.
&nbsp;This 258,000 square-foot industrial asset in Harford County, Maryland represents exactly the type of modern logistics facility that companies need as they restructure supply chains closer to population centers.
I find the company&#8217;s industrial strategy particularly well-timed. FRP Holding aims to double its industrial segment over five years by delivering three new industrial assets every two years.
This aggressive expansion targets markets where demand for modern warehouse and distribution facilities continues growing while new supply remains constrained.
One of the most compelling aspects of FRP Holdings that involves its ownership structure and management alignment. The Baker family owns approximately 35% of the company, with the CEO owning 14.8% and other family members owning an additional 20.8%.
Company CEO John Baker is the largest shareholder with 15% of shares outstanding.
This represents serious skin in the game.
&nbsp;When management owns more than one-third of the business, their interests align perfectly with my interests as an outside shareholder.
The Baker family has shown that they are willing to sell if the right offer presents itself, which creates substantial shareholder value.
They have also demonstrated disciplined capital allocation, evidenced by the company repurchasing $20 million of shares during the pandemic below NAV.
I see FRP Holding's development pipeline providing multiple catalysts for future growth. In 2025, the company anticipates moving forward with two multifamily projects outside the DC area, one in South Carolina and the other in southwest Florida.
The company&#8217;s development expertise spans nearly four decades. Through its subsidiaries, FRP Development Corp &amp; Florida Rock Properties, Inc., FRP Holdings has nearly 40 years of development experience.
Several factors contribute to FRP Holding's relative obscurity among investors, which I view as an opportunity. FRP Holdings is covered by 4 analysts, with 0 of those analysts submitting estimates of revenue or earnings used as inputs to reports. The company operates in unfashionable sectors, mining royalties, apartment buildings, and warehouses, rather than the technology or growth companies that capture headlines.
FRPH does not currently pay a dividend, which eliminates income-focused investors from the shareholder base.
The company&#8217;s complex structure across multiple real estate segments requires more analysis than most investors want to undertake. This complexity creates the opportunity for those of us willing to do the work.
I believe FRP Holdings represents everything attractive about the commercial real estate opportunity I described. The company combines steady cash flows from mining royalties, growth potential from industrial development, and strategic positioning in recession-resistant Washington D.C. multifamily markets.
Management owns more than one-third of the business and has demonstrated disciplined capital allocation over decades.
This combination of quality assets, aligned management, and market neglect creates exactly the type of contrarian opportunity that I believe patient investors should embrace.
For investors willing to step into the liver and onions of today&#8217;s financial markets, I see FRP Holdings offering compelling exposure to the commercial real estate renaissance that nobody wants to discuss. The best investments you will ever make are those where almost nobody else agrees with you, and right here, almost nobody is paying attention to FRP Holdings.

Opinion

CBRE

FRPH

SBUX

Under the Radar: The Contrarian Case for Commercial Real Estate Is Getting Stronger

Amazon Pharmacy has announced two updates to make medication management easier and more accessible for millions of customers across the U.S., especially caregivers <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">and Medicare patients</a>.
The enhancements include a new caregiver feature and expanded access to its PillPack service for Medicare beneficiaries.
The caregiver support <a target="_blank" href="https://www.aboutamazon.com/news/retail/amazon-pharmacy-caregiver-medicare-pillpack" rel="noreferrer noopener">feature</a> allows Amazon Pharmacy customers to invite trusted individuals to manage medications on their behalf.
Once verified, caregivers can oversee prescriptions through their own Amazon accounts.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/06/45748544/walmart-leverages-automation-and-ai-to-cut-costs-and-grow-paving-the-way-for-other-retailers-report" rel="noreferrer noopener">Walmart Leverages Automation And AI To Cut Costs And Grow, Paving The Way For Other Retailers: Report</a>
According to AARP, this update addresses a growing need: One in five U.S. adults, or about 53 million people, cares for an aging family member. Many spend the equivalent of a full workday each month coordinating health care, with medication management being among the most complex tasks.
Setting up caregiver access is simple: A customer logs into their Amazon Pharmacy account and sends an invitation via mobile phone number. After verifying a few details, like the customer&#8217;s date of birth, the caregiver receives a secure link by text message and can begin managing prescriptions from their account.
In addition, Amazon Pharmacy has expanded access to its PillPack service for Medicare Part D members.
PillPack offers personalized medication packets organized by date and time, designed to simplify the daily routine of people taking multiple prescriptions.
This service is now available to over 50 million Medicare Part D beneficiaries, helping eliminate the burden of sorting pills and tracking refill schedules. Eligible customers can sign up through their Amazon Pharmacy account to enroll.
Customers will receive monthly pre-sorted packet shipments after reviewing their medications and insurance details. Amazon coordinates all refills so medications arrive together each month.
Amazon Pharmacy offers one-time prescriptions and ongoing medication needs through the Amazon app.
The platform provides delivery updates via text or email and offers Prime members in select cities—including New York City, Los Angeles, and Seattle—free same-day delivery.
The pharmacy accepts most major insurance plans, including Medicare Part D nationwide and Medicaid in select states.
Prime members benefit from additional savings through RxPass and other Prime-exclusive discounts, with potential savings of up to 80% on thousands of medications when paying without insurance.
PillPack services are free and include 24/7 access to pharmacists and monthly medication deliveries.
Amazon bought PillPack seven years ago for over $750 million, but it still hasn&#8217;t revealed how much money its Amazon Pharmacy business is making in its quarterly earnings.
According to Forbes, <a href="https://www.forbes.com/sites/brucejapsen/2025/06/03/amazon-a-tiny-pharmacy-player-seeks-to-dent-cvs-and-walgreens-medicare-share/" target="_blank" rel="noreferrer noopener">studies</a> show that CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) and Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) owned Walgreens control about 40% of the U.S. prescription drug market combined, while Amazon holds less than 1%. CVS and Walgreens do not share how many Medicare Part D prescriptions they fill.
Now, Amazon Pharmacy is adding features aimed at seniors to break into the fast-growing Medicare market, as more than 11,000 Americans turn 65 daily.
Most recently, Talkspace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TALK#NASDAQ">TALK</a>), an online behavioral health company, collaborated with Amazon Pharmacy to simplify the pharmacy experience for Talkspace members and streamline medication management and adherence support for providers.
Talkspace members can <a target="_blank" href="https://www.businesswire.com/news/home/20250529796020/en/Talkspace-Becomes-First-Behavioral-Health-Provider-to-Integrate-with-Amazon-Pharmacy-Offering-Psychiatry-Services-and-a-More-Seamless-Medication-Management-Experience" rel="noreferrer noopener">fulfill</a> prescriptions from their Talkspace provider through Amazon Pharmacy.
Price Action: AMZN stock is up 0.49% at $207.67 at the last check on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/06/45745834/nio-stock-drops-after-q1-results-and-outlook-disappoints-the-street-margins-shrink" target="_blank" rel="noreferrer noopener">Nio Stock Drops After Q1 Results And Outlook Disappoints The Street, Margins Shrink</a></li>
</ul>
Photo by MACH Photos via Shutterstock

AMZN

TALK

Amazon Pharmacy Challenges CVS Health And Walgreens Dominance, Unveils New Features To Expand Medicare Access

Walgreens Boots Alliance's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NYSE">WBA</a>) short percent of float has fallen 7.68% since its last report. The company recently reported that it has 33.89 million shares sold short, which is 4.69% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Walgreens Boots Alliance Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745856022_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Walgreens Boots Alliance has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Walgreens Boots Alliance's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Walgreens Boots Alliance's peer group average for short interest as a percentage of float is 4.43%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Peering Into Walgreens Boots Alliance's Recent Short Interest

Walgreens Has Teamed Up With Guild To Launch PharmStart, A First-of-its-kind, Fully Funded Online Education Program Designed To Help Eligible Team Members Meet The Prerequisite Requirements For Pharmacy School

Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) on Monday said it will pay $300 million to resolve federal allegations that the company filled millions of invalid prescriptions for opioids <a href="https://www.benzinga.com/topic/opioids">and other controlled substances</a>.
Earlier this year, the U.S. Department of Justice filed a civil complaint against Walgreens and its subsidiaries, alleging widespread violations of the Controlled Substances Act (CSA) and <a href="https://www.benzinga.com/25/01/43104245/justice-department-accuses-walgreens-of-violating-drug-laws-in-opioid-epidemic-ignored-red-flags-in-opioid-crisis" target="_blank" rel="noreferrer noopener">False Claims Act (FCA)</a>.
The settlement, announced by the Justice Department, Drug Enforcement Administration (DEA), and the Department of Health and Human Services Office of Inspector General (HHS-OIG), addresses violations of the Controlled Substances Act and False Claims Act.
An additional $50 million will be <a target="_blank" href="https://www.justice.gov/opa/pr/walgreens-agrees-pay-350m-illegally-filling-unlawful-opioid-prescriptions-and-submitting" rel="noreferrer noopener">owed</a> if Walgreens is sold or merged before fiscal year 2032.
Sycamore Partners agreed to acquire Walgreens for $11.45 per <a href="https://www.benzinga.com/25/03/44377660/walgreens-executive-chair-stefano-pessina-seeks-to-strengthen-control-with-nearly-double-stake" target="_blank" rel="noreferrer noopener">share in March</a>.
Federal authorities alleged that from August 2012 to March 2023, Walgreens knowingly dispensed millions of controlled substance prescriptions that raised serious red flags.
These included excessive opioid quantities, early refills, and combinations known as the "trinity," a high-risk cocktail of drugs often linked to abuse. Despite clear signs these prescriptions lacked legitimate medical purposes, Walgreens pharmacists were allegedly pressured to prioritize speed over due diligence.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/44685591/walgreens-boots-alliance-q2-earnings-beats-expectations-suspends-guidance-amid-pending-private-equity-deal-with-sycamore-partners" rel="noreferrer noopener">Walgreens Boots Alliance Q2 Profit Falls 47.5%, Suspends Guidance On Pending Private Equity Deal</a>
According to the complaint, Walgreens&#8217; internal practices further contributed to the misconduct. Compliance officials reportedly failed to act on substantial evidence of unlawful dispensing. The company allegedly withheld critical information from pharmacists, including internal prescriber data, and blocked efforts to warn colleagues about potentially problematic prescribers.
The Justice Department accused Walgreens of creating an environment that discouraged pharmacists from taking necessary steps to ensure valid prescriptions.
Alongside the financial settlement, Walgreens has agreed to implement long-term compliance measures. For example, it will require pharmacists to verify the legitimacy of controlled substance prescriptions. It will also conduct annual training, and ensure staffing levels support legal compliance.
Walgreens must also block prescriptions from prescribers known to issue illegitimate prescriptions.
Separately, Walgreens entered into a five-year Corporate Integrity Agreement with HHS-OIG, which establishes a comprehensive compliance program. The process includes employee training, oversight by the company's board, and regular reporting to HHS-OIG regarding controlled substances.
Following the settlement, the U.S. government moved to dismiss its complaint. Walgreens will seek to dismiss a related declaratory judgment case filed in Texas.
In November, Walgreens agreed to pay $100 million to settle a proposed class action lawsuit over its <a href="https://www.benzinga.com/news/large-cap/24/11/41741814/walgreens-agrees-to-100-million-settlement-over-alleged-deceptive-pricing-of-generic-drugs">Prescription Savings Club</a>.
Price Action: Walgreens stock is down 0.46% at $10.84 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44903741/fda-eases-monitoring-requirements-for-bristol-myers-heart-drug-camzyos-analyst-sees-as-timely-boost-ahead-of-rivals-review" target="_blank" rel="noreferrer noopener">Bristol Myers Analyst Says FDA Update Is A Win For Camzyos With Simpler Use, Broader Reach</a></li>
</ul>
Image: Shutterstock

Legal

Walgreens Must Pay $300 Million In Opioid Case, Additional $50 Million If Sold Or Merged Before 2032

<a href="https://www.justice.gov/opa/pr/walgreens-agrees-pay-350m-illegally-filling-unlawful-opioid-prescriptions-and-submitting" title="https://www.justice.gov/opa/pr/walgreens-agrees-pay-350m-illegally-filling-unlawful-opioid-prescriptions-and-submitting">https://www.justice.gov/opa/pr/walgreens-agrees-pay-350m-illegally-filling-unlawful-opioid-prescriptions-and-submitting</a>

Reported Earlier: 'Walgreens Agrees To Pay Up To $350M For Illegally Filling Unlawful Opioid Prescriptions And For Submitting False Claims To The Federal Government'

Walgreens Boots Alliance's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NYSE">WBA</a>) short percent of float has fallen 20.13% since its last report. The company recently reported that it has 36.69 million shares sold short, which is 5.08% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.63 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Walgreens Boots Alliance Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744380030_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Walgreens Boots Alliance has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Walgreens Boots Alliance's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Walgreens Boots Alliance's peer group average for short interest as a percentage of float is 5.19%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What Does the Market Think About Walgreens Boots Alliance?

Press Releases

Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline

Walgreens Committed to Supporting Rite Aid Customers and Employees

U.S. Heating Pads Market Report 2023-2029: Bear Down Brands, LLC., Beurer and Conair LLC are the Major Stakeholders – Focus Report Store

Walgreens Expands Micro-Fulfillment Network with New Facility in Brooklyn Park, Minnesota

Synergy CHC Corp. (NASDAQ: SNYR) Taps Beverage Veteran to Drive FOCUSfactor's Drink Expansion – More Stocks Inside

Synergy CHC Corp. (NASDAQ: SNYR) Restructures Debt with $20M Facility to Power Global Growth and FOCUSfactor Beverage Expansion

Synergy CHC (NASDAQ: SNYR) Taps Coca-Cola Exec to Accelerate Global Expansion of "FOCUSfactor®" Energy Drink – More Stocks Moving Inside

LiveRamp and Walgreens Advertising Group Deliver Business Growth for Advertisers Through Robust Data Collaboration Partnership

Walgreens and KFF's Greater Than Campaign to Offer Free HIV/STD Testing in Stores on June 27

Walgreens Boots Alliance Reports Fiscal 2025 Third Quarter Results

ALZN

BAOS

CLRB

EVGN

HTCR

KLTO

MGNX

MODV

NAOV

NCEW

PLUG

PNPNF

RAMP

SNYR

TSXV:PNPN

WINT

Guardian Pharmacy Services, Inc. Class A Common Stock

Guardian Pharmacy Service

Mangoceuticals

Ridgetech

Deutsche Bank

Truist Securities

RBC Capital

Evercore ISI Group

B of A Securities

Screenshot 2025-03-18 at 5.59.12 PM

Fintech news covering the emerging Financial Technology services sector

Fintech

AMOD

VSBGF

Alpha Modus: Helping Set IP Leadership Standards And Usher In A New Era Of Innovation In Retail AI

Screenshot 2025-02-21 at 6.41.09 PM

Emerging Markets

Movers & Shakers

From Innovating To Protecting Its Shareholders: Alpha Modus&#39;s Strategy To Transform The Retail Market

Comments

Walgreens Boots Alliance

Interés en corto

Walgreens Boots Alliance (NASDAQ:WBA) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL